Applicability of the lung immune prognostic index (LIPI) in patients with metastatic solid tumors when treated with immune checkpoint inhibitors (ICI) in early clinical trials

被引：0
|
作者：
Varga, A. [1 ]
Bernard-Tessier, A. [2 ]
Auclin, E. [3 ]
Perez, L. Mezquita [2 ]
Baldini, C. [1 ]
Planchard, D. [2 ]
Marabelle, A. [1 ]
Hollebecque, A. [1 ]
Besse, B. [2 ]
Massard, C. [1 ]
机构：
[1] Gustave Roussy Canc Campus, Drug Dev Dept, Villejuif, France
[2] Gustave Roussy Canc Campus, Dept Canc Med, Villejuif, France
[3] Hop European George Pompidou, Oncol, Paris, France
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3O
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Validation of the Lung Immune Prognostic Index (LIPI): Useful to Identify Resistance to PD-1 Checkpoint Inhibitors in Pretreated Lung Cancer
    Mielgo-Rubio, X.
    Sereno Moyano, M.
    Sotelo-Lezama, M.
    Lopez Castro, R.
    Rubio-Martinez, J.
    Velastegui, A.
    Olier-Garate, C.
    Falagan, S.
    Gomez-Barreda, I.
    Riquelme, A.
    Cardena-Gutierrez, A.
    Moreno Rubio, J.
    Lopez, C.
    Bueno, C.
    -Ruiz, J. Silva
    Zhou, E. Zhan
    Chara, L.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S488 - S489
  • [32] The LIPI score and inflammatory biomarkers for selection of patients with solid tumors treated with checkpoint inhibitors
    Benitez, Jose C.
    Recondo, Gonzalo
    Rassy, Elie
    Mezquita, Laura
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 64 (02): : 162 - 174
  • [33] Association of the LIPI With Survival and Response in Advanced NSCLC Patients Treated With Immune Checkpoint Inhibitors
    Zhi, X.
    Zhang, Z.
    Li, W.
    Yan, X.
    Zhang, F.
    Han, X.
    Yuan, F.
    Ma, J.
    Wang, L.
    Tao, H.
    Li, X.
    Zhang, S.
    Ge, X.
    Hu, Y.
    Wang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S582 - S582
  • [34] Immune profile analysis of peripheral blood and tumors of lung cancer patients treated with immune checkpoint inhibitors
    Ichiki, Yoshinobu
    Fukuyama, Takashi
    Ueno, Mari
    Kanasaki, Yoshiro
    Goto, Hidenori
    Takahashi, Mai
    Mikami, Shuji
    Kobayashi, Noritada
    Nakanishi, Kozo
    Hayashi, Shinichi
    Ishida, Tsuyoshi
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022, : 2192 - 2207
  • [35] Hyperprogressive disease in patients with metastatic genitourinary tumors treated with immune checkpoint inhibitors.
    Suarez, Cristina
    Morales-Barrera, Rafael
    Garcia-Ruiz, Alonso
    Gonzalez, Macarena
    Ligero, Marta
    Valverde, Claudia
    Serrano, Cesar
    Mateo, Joaquin
    Perez-Lopez, Raquel
    Carles, Joan
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [36] Prognostic value of systemic immune-inflammation index in patients with small-cell lung cancer treated with immune checkpoint inhibitors
    Hamakawa, Yusuke
    Hirahara, Ayumi
    Hayashi, Akiko
    Ito, Kota
    Shinohara, Hiroyuki
    Shiba, Aya
    Higashi, Yuko
    Aga, Masaharu
    Miyazaki, Kazuhito
    Taniguchi, Yuri
    Misumi, Yuki
    Agemi, Yoko
    Nakamura, Yukiko
    Shimokawa, Tsuneo
    Okamoto, Hiroaki
    BMC CANCER, 2025, 25 (01)
  • [37] Development of an immunological prognostic Signature in metastatic Patients who were treated with Immune Checkpoint Inhibitors as part of the ST-ICI Study
    Zhou, J-G
    Donaubauer, A. -J
    Frey, B.
    Becker, I
    Rutzner, S.
    Sun, R.
    Ma, H.
    Fietkau, R.
    Deutsch, E.
    Hecht, M.
    Gaipl, U.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (SUPPL 1) : S27 - S28
  • [38] Baseline modified Glasgow prognostic score (mGPS) in patients with metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors (ICI).
    Brown, Jacqueline T.
    Liu, Yuan
    Martini, Dylan J.
    Shabto, Julie M.
    Russler, Greta
    Caulfield, Sarah
    Yantorni, Lauren Beth
    Joshi, Shreyas S.
    Kissick, Haydn
    Ogan, Kenneth
    Nazha, Bassel
    Carthon, Bradley Curtis
    Kucuk, Omer
    Harris, Wayne
    Master, Viraj A.
    Bilen, Mehmet Asim
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [39] CLINICAL OUTCOMES AND TOXICITY PROFILE OF PATIENTS WITH PRIMARY CARDIAC TUMORS TREATED WITH IMMUNE CHECKPOINT INHIBITORS <ICI>
    Abou Alaiwi, Sarah
    Nassar, Amin
    Zarif, Talal
    Macaron, Walid
    Denu, Ryan
    Freeman, Dory
    Abdel-Wahab, Noha
    El-Am, Edward
    Al-Hader, Ahmad
    Malvar, Carmel
    Mckay, Rana
    Padera, Robert
    Neilan, Tomas G.
    Choueiri, Toni
    Naqash, Abdul-Rafeh
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 2336 - 2336
  • [40] Surgery in patients with metastatic melanoma treated with immune checkpoint inhibitors
    Janssen, Josephine C.
    Huibers, Anne E.
    Grunhagen, Dirk J.
    Bagge, Roger Olofsson
    SCANDINAVIAN JOURNAL OF SURGERY, 2025,
12345